background

🔬 Laboratory

Together with our collaborators, we are building local capacity in laboratory research for infectious diseases using ELISA, PCR, qPCR, and nanopore sequencing. This integrated platform enables early detection, monitoring, and characterization of pathogens.

🔬 ELISA (Enzyme-Linked Immunosorbent Assay)

  • Purpose: Detects antigens or antibodies in blood or other samples.
  • Use: Common in serological testing (e.g., HIV, hepatitis, dengue).
  • Strengths: High specificity, cost-effective, scalable for large populations.

🧬 PCR & qPCR (Polymerase Chain Reaction)

  • Purpose: Amplifies DNA/RNA sequences to detect pathogens.
  • Use:
    • PCR: Identifies presence of pathogen DNA/RNA.
    • qPCR: Quantifies pathogen genetic material for viral load monitoring.
  • Strengths: High sensitivity and specificity, fast turnaround, clinical-grade diagnostics.

🧫 Nanopore Sequencing

  • Purpose: Real-time DNA/RNA sequencing using nanopores.
  • Use:
    • Identifies unknown or emerging pathogens.
    • Tracks mutations and resistance genes.
    • Supports metagenomics directly from clinical samples.
  • Strengths: Portable, real-time data, long-read capability, ideal for outbreak settings.

🧪 Integrated Applications

This multi-method approach enables:

  • Screening: via ELISA
  • Confirmation & Quantification: using PCR/qPCR
  • Genomic Analysis: through nanopore sequencing

Useful in:

  • Outbreak investigation
  • Antimicrobial resistance (AMR) surveillance
  • Zoonotic disease monitoring